Activity and tolerance of a continuous subcutaneous infusion of interferon-α2b in patients with chronic hepatitis C

Journal of Interferon and Cytokine Research

Volumn 17, Issue 11, 1997, Pages 665-670

  Schenker, Steven ^a,d   Cutler, David ^b   Finch, Joan ^a   Tamburro, Carlo H ^c   Affrime, Melton ^b   Sabo, Ron ^b   Bay, Michael ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c University of Louisville School of Medicine   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HUMAN; IMMUNOLOGICAL TOLERANCE; LIVER FUNCTION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

HEPATITIS C VIRUS;

EID: 0030686567     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1997.17.665     Document Type: Article

References (10)

1. DAVIS, G.L., BALART, L.A., SCHIFF, E.R., LINDSAY, K., BODENHEIMER, H.C., Jr., PERRILLO, R.P., CAREY, W., JACOBSON, I.M., PAYNE, J., DIENSTAG, J.L., et al. (1989). Treatment of chronic hepatitis C with recombinant interferon alfa. N. Engl. J. Med. 321, 1501-1506.
2. TINE, F., MAGRIN, S., CRAXI, A., and PAGLIARO, L. (1991). Interferon for chronic non-A, non-B hepatitis: a meta-analysis of randomized clinical trials. J. Hepatol. 13, 192-199.
3. MARCELLIN, P., BOYER, N., MARTINOT-PEIGNOUX, M., AREIAS, J., GIOSTRA, E., DEGOTT, C., ERLINGER, S., and BENHAMOU, J.P. (1992). Long-term histologic changes and detection of HCV RNA by polymerase chain reaction (PCR) in patients with chronic hepatitis C having responded to recombinant alpha interferon Hepatology 16, 65A (abstract).
4. SARACCO, G., ROSINA, F., ABATE, M.L., CHIANDUSSI, L., GALLO, V., CERUTTI, E., Di NAPOLI, A., SOLINAS, A., DEPLANO, A., TOCCO, A., COSSU, P., CHIEN, D., KUO, G., POLITO, A., WEINER, A.J., HOUGHTON, M., VERME, G., BONIMO, F., and RIZZETTO, M. (1993). Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon α-2b. Hepatology 18, 1300-1305.
5. JOUET, P., ROUDOT-THORAVAL, F., DHUMAUX, D., METREAU, J.M., and LE GROUPE FRANCAIS POUR L'ETUDE DU TRAITEMENT DES HEPATITES CHRONIQUES NANB/C. (1994). Comparative efficacy of interferon alfa in cirrhotic and non-cirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology 106, 686-690.
6. RADWANSKI, E., PERENTESIS, G., JACOBS, S., ODEN, E., AFFRIME, M., SYMCHOWICZ, S., and ZAMPAGLIONE, N. (1987). Pharmacokinetics of interferon α-2b in healthy volunteers. J. Clin. Pharmacol. 27, 432-435.
7. DORR, R.T., SALMON, S.E., ROBERTONE, A., and BONNEM, E. (1988). Phase I-II trial of interferon-α2b by continuous subcutaneous infusion over 28 days. J. Interferon Res. 8, 717-725.
8. DiBISCEGLIE, A.M., MARTIN, P., KASSIANIDES, C., LISKER-MELMAN, M., MURRAY, L., WAGGONER, J., GOODMAN, Z., BANKS, S.M., and HOOFNAGLE, J.H. (1989). Recombinant interferon alfa therapy for chronic hepatitic C. N. Engl. J. Med. 321, 1506-1510.
9. PETERS, M. (1989). Mechanisms of action of interferons. Semin. Liver Dis. 9, 235-239.
10. CARREÑO, V., TAPIA, L., RYFF, J.-C., QUIROGA, J.A., and CASTILLO, I. (1992). Treatment of chronic hepatitis C by continuous subcutaneous infusion of interferon-alpha. J. Med. Virol. 37, 215-219.